Ari M. Vanderwalde
Ari M. Vanderwalde publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, on topics such as Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics and Cancer Immunotherapy and Biomarkers.
- World rank
- #522,102 of 7,710,434 ranked researchers
- Rank in United States
- #181,278 of 1,627,098
- Works
- 530
- Citations
- 8.6k
- Citations per work
- 16.3
What does Ari M. Vanderwalde research?
Ari M. Vanderwalde's work is mostly in Medicine (49%), Biochemistry, Genetics and Molecular Biology (24%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences26049.0%
- Medicine26049.0%
- Everything else14226.8%
- Life Sciences12824.2%
- 1Oncology29% of their works
- 2Pulmonary and Respiratory Medicine15% of their works
- 3Molecular Biology11% of their works
- 4Cancer Research9% of their works
- 5Surgery5% of their works
- 6Genetics4% of their works
Research topics
Which keywords describe Ari M. Vanderwalde's research?
The keywords of their largest research topics: Targeted Therapy, Clinical Trials, ALK Inhibitors, EGFR Mutations, Immunotherapy, Cancer Genomics, Mutational Signatures and Chemotherapy.
- Viral Vectors
- Genomic Profiles
- MAP Kinase
- Cetuximab
- Chimeric Antigen Receptor
- PD-1 and PD-L1
- Chemotherapy
- Cancer Genomics
- EGFR Mutations
- Clinical Trials
- Targeted Therapy
- ALK Inhibitors
- Immunotherapy
- Mutational Signatures
- Immune Checkpoint Blockade
- CAR T Cells
- BRAF gene
- KRAS Mutations
- Gene Therapy
- Small-Cell Lung Cancer
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Targeted Therapy1413 topics
- Clinical Trials912 topics
- ALK Inhibitors691 topic
- EGFR Mutations691 topic
- Immunotherapy582 topics
- Cancer Genomics501 topic
- Mutational Signatures501 topic
- Chemotherapy462 topics
- Immune Checkpoint Blockade451 topic
- PD-1 and PD-L1451 topic
- CAR T Cells361 topic
- Chimeric Antigen Receptor361 topic
- BRAF gene241 topic
- Cetuximab241 topic
- KRAS Mutations241 topic
- MAP Kinase241 topic
- Gene Therapy221 topic
- Genomic Profiles221 topic
- Small-Cell Lung Cancer221 topic
- Viral Vectors221 topic
Where does Ari M. Vanderwalde work?
Ari M. Vanderwalde's main affiliation in the publication record is Caris Life Sciences (United States), United States.
How many publications and citations does Ari M. Vanderwalde have?
OpenAlex counts 530 works and 8,630 citations for Ari M. Vanderwalde, an h-index of 32, ranking #522,102 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Ari M. Vanderwalde. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.